RPS InflammaDry Detector™ to Determine MMP-9 Levels in Tears
NCT01313351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206
Last updated 2022-12-12
Summary
The RPS InflammaDry Detector™ is intended to detect elevated MMP-9 in human tears to aid in the diagnosis of patients with signs or symptoms of dry eye disease, in conjunction with other methods of clinical evaluation.
Conditions
- Dry Eye
Interventions
- DEVICE
-
RPS InflammaDry Detector™
A noninvasive immunoassay for detecting MMP-9 levels in tears
Sponsors & Collaborators
-
Rapid Pathogen Screening
lead INDUSTRY
Principal Investigators
-
Robert Sambursky, MD · Rapid Pathogen Screening, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2011-10-31
- Completion
- 2011-10-31
Countries
- United States
Study Locations
More Related Trials
-
Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
NCT02824913 ·Status: TERMINATED ·Phase: PHASE2
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye
NCT02257957 ·Status: COMPLETED ·Phase: PHASE3
-
Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
NCT00567177 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnostic Evaluation of the Tear Film
NCT00761917 ·Status: COMPLETED
-
TrueTear in Sjogren's Disease Patients
NCT03719885 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome
NCT06831253 ·Status: RECRUITING ·Phase: NA
-
Effect of Lifitegrast 5% on Tear Film Markers
NCT03952481 ·Status: WITHDRAWN ·Phase: PHASE4
-
Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
NCT03333057 ·Status: COMPLETED ·Phase: PHASE2
-
TearCare System to Treat Dry Eye Disease
NCT03857919 ·Status: COMPLETED ·Phase: NA
-
Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye
NCT05121493 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome
NCT07277257 ·Status: RECRUITING ·Phase: PHASE4
-
Tear Osmolarity Clinical Utility in Dry Eye Disease
NCT02417116 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Tear Film Dynamic Measurements in Normal, MGD and ADDE Subjects After Saline Instillation
NCT01128049 ·Status: COMPLETED ·Phase: NA
-
Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ Use
NCT03274999 ·Status: TERMINATED ·Phase: NA
-
The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora
NCT02240615 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye
NCT03183089 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
NCT05618730 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
NCT04030962 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of NOV03 on the Tear Film
NCT05723770 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye
NCT01319773 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
Photobiomodulation in Combination With Topical Cyclosporine A or Tacrolimus
NCT07239128 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Impairment of Reading Ability in Dry Eye Patients
NCT01826812 ·Status: COMPLETED
-
Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease
NCT03827564 ·Status: TERMINATED ·Phase: NA